Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Vaxcyte, Inc. (PCVX : NSDQ)

• Company Description    Vaxcyte Inc.is a biopharmaceutical company develops vaccines for infectious diseases. It offers conjugate, pneumococcal conjugate and complex antigen-based vaccines. Vaxcyte Inc.is based in Foster City, California. Number of Employees: 507

• Price / Volume Information    Yesterday's Closing Price: $60.43 Daily Weekly Monthly 20 Day Moving Average: 3,854,366 shares Shares Outstanding: 148.80 (millions) Market Capitalization: $8,992.29 (millions) Beta: 1.23 52 Week High: $90.75 52 Week Low: $39.87 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 6.20% 7.33% 12 Week 7.99% 5.35% Year To Date 30.97% 21.68%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 825 INDUSTRIAL ROAD SUITE 300 - SAN CARLOS,CA 94070 USA ph: 650-837-0111 fax: - investors@vaxcyte.com http://www.vaxcyte.com

• General Corporate Information    Officers Grant E. Pickering - Chief Executive Officer and Director Andrew Guggenhime - President and Chief Financial Officer Elvia Cowan - Senior Vice President; Finance and Chief Accountin Carlos Paya - Director Olivier Brandicourt - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 92243G108 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/03/26 Share - Related Items Shares Outstanding: 148.80 Most Recent Split Date: (:1) Beta: 1.23 Market Capitalization: $8,992.29 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-1.83 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-7.47 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/03/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.16 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -61.48% vs. Previous Quarter: 14.35% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 09/30/26 - - 06/30/26 - -37.56 03/31/26 - -32.51 ROA 09/30/26 - - 06/30/26 - -33.62 03/31/26 - -29.51 Current Ratio 09/30/26 - - 06/30/26 - 5.72 03/31/26 - 7.49 Quick Ratio 09/30/26 - - 06/30/26 - 5.72 03/31/26 - 7.49 Operating Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Net Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Pre-Tax Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Book Value 09/30/26 - - 06/30/26 - 19.10 03/31/26 - 20.75 Inventory Turnover 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Equity 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00 Debt-to-Capital 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00

Powered by Zacks Investment Research ©